Ask AI

On-Demand Webcast

Share

Program Content

Activities

  • HR positive HER2 negative BC Targeted Therapy Options
    Fundamentals III: Targeted Therapy Options in HR-Positive/ HER2-Negative Breast Cancer
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 06, 2026

    Expires: November 05, 2026

  • Optimizing Therapy in High Risk HR Positive HER2 Negative EBC
    Fundamentals I: Optimizing Adjuvant Therapy in Patients With High-Risk HR+/HER2- EBC
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 06, 2026

    Expires: November 05, 2026

Provided by

ProCE Banner

Provided by Partners for Advancing Clinical Education (Partners) in partnership with Clinical Care Options, LLC dba Decera Clinical Education.

 

Supporters

This activity is supported by an educational grant from Lilly.

Lilly

Partners

Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner